Reconciliation Analyst

McKesson’s Corporate; Tennessee; Hybrid; USD 42,000 - 64,000; Full time

Job summary

Sarah Cannon Research Institute (SCRI) is seeking a Clinical Reconciliation Specialist for a remote role based in the United States. You will reconcile clinical trial receivables, review data from multiple sources, and ensure accurate billing to sponsors.

The position requires a Bachelor's degree and 1-2 years in accounting or finance within healthcare or clinical trial settings. Proficiency with Excel and QuickBooks is expected, with strong analytical skills.

Qualifications

• Bachelor's Degree required.
• 1-2 years' work experience in Accounting or Finance in a medical, clinical trial research or healthcare-related environment.
• Experience with Microsoft products including above average use of Excel and financial accounting systems such as QuickBooks.
• Knowledge of research techniques to analyze and evaluate financial data and information.

Responsibilities

• Reconcile in detail clinical trial receivables to ensure final billing to pharmaceutical companies is accurate and timely.
• Reconcile Sarah Cannon financial study data across multiple sources.
• Review and interpret contracts and budgets.
• Work with operations and other departments to resolve variances.
• Respond to requests for information from Corporate, Internal Audit, Operations and Management.
• Perform Analysis of contracted revenue triggers to determine eligibility for reimbursement.
• Ensure that all processing and reporting deadlines are consistently achieved.
• Other duties as assigned.

Skills

Bachelor's degree

Accounting

Finance

Excel

Financial analysis

Education

Bachelor's Degree

Tools

QuickBooks

Job description

It’s More Than a Career, It’s a Mission. Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day. Our Mission People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting‑edge research, SCRI is redefining cancer care around the world. Our Clinical Reconciliation Specialist is responsible for the reconciliation of client receivables in accordance with contractual agreements. Includes review of all Clinical Trial revenues and expenses, as well as interaction with various departments in order to determine the validity of charges and payments received from sponsors. This is a remote position based in the US; relocation assistance and visa sponsorship are not available.

Key Responsibilities

• Reconcile in detail clinical trial receivables to ensure final billing to pharmaceutical companies is accurate and timely
• Reconcile Sarah Cannon financial study data across multiple sources.
• Review and interpret contracts and budgets
• Work with operations and other departments to resolve variances
• Respond to requests for information from Corporate, Internal Audit, Operations and Management
• Perform Analysis of contracted revenue triggers to determine eligibility for reimbursement.
• Ensure that all processing and reporting deadlines are consistently achieved.
• Other duties as assigned.

Qualifications

• Bachelor's Degree required
• 1-2 years' work experience in Accounting or Finance in a medical, clinical trial research or healthcare-related environment
• Experience with Microsoft products including above average use of Excel and financial accounting systems such as Quickbooks
• Knowledge of research techniques to analyze and evaluate financial data and information.

About Sarah Cannon Research Institute

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first‑in‑human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S. Please click here to learn more about our research offerings.

Benefits & Compensation

We care about the well‑being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well‑being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here.

As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long‑term incentive opportunities may be offered.

Equal Opportunity

We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.